[Back to http://www.nycagainstrape.org/home/nycaasa/stage.nycagainstrape.org/survivors_factsheet_series_19.html]

Alliance Logo

Alliance: FAQ and Factsheets: Office of National Drug Control Policy


FAQ and Factsheets: Office of National Drug Control Policy

The Drug Policy Information Clearinghouse is funded by the White House Office of National Drug Control Policy, and is a component of the National Criminal Justice Reference Service. The principal purpose of ONDCP is to establish policies, priorities, and objectives for the Nation's drug control program. The goals of the program are to reduce illicit drug use, manufacturing, and trafficking, drug-related crime and violence, and drug-related health consequences. By law, the Director of ONDCP also evaluates, coordinates, and oversees both the international and domestic anti-drug efforts of executive branch agencies and ensures that such efforts sustain and complement State and local anti-drug activities

[1] Rohypnol
Illicit use of Rohypnol began in the 1970s in Europe and appeared in the United States in the early 1990s. Much of the concern surrounding Rohypnol is its abuse as a "date rape" drug. Rohypnol is a tasteless and odorless drug and, until recent manufacturer efforts, dissolved clear in liquid, which masked its presence. Drug-facilitated rape can be defined as sexual assault made easier by the offender’s use of an "anesthesia" type drug that can render the victim physically incapacitated or helpless and unable to give consent to sexual activity. Whether the victim is unwittingly administered the drug or willingly ingests it for recreational use is irrelevant. The person is victimized because of an inability to consciously consent to sexual acts. [[2] More...]
[3] Gamma Hyroxybutyrate (GHB)
Gamma hydroxybutyrate (GHB) is a powerful, rapidly acting central nervous system depressant. GHB is abused for its ability to produce euphoric and hallucinogenic states and for its alleged function as a growth hormone that releases agents to stimulate muscle growth. GHB became a Schedule I Controlled Substance in March 2000. According to NDIC, GHB has surpassed Rohypnol (flunitrazepam) as the most common substance used in drug-facilitated sexual assaults. GHB can mentally and physically paralyze an individual, and these effects are intensified when the drug is combined with alcohol. [[4] More...]

[1]: http://www.nycagainstrape.org/home/nycaasa/stage.nycagainstrape.org/survivors_factsheet_115.html
[2]: http://www.nycagainstrape.org/home/nycaasa/stage.nycagainstrape.org/survivors_factsheet_115.html
[3]: http://www.nycagainstrape.org/home/nycaasa/stage.nycagainstrape.org/survivors_factsheet_114.html
[4]: http://www.nycagainstrape.org/home/nycaasa/stage.nycagainstrape.org/survivors_factsheet_114.html

Copyright © 2000-2008 by The New York City Alliance Against Sexual Assault

[Back to http://www.nycagainstrape.org/home/nycaasa/stage.nycagainstrape.org/survivors_factsheet_series_19.html]